2022 CTAD Poster
POSTER PRESENTATION CTAD 2022:
Critical evaluation and comparison of biomarker values in commercial CSF with Lumipulse® to support assay development for clinical trials.
POSTER PRESENTATION CTAD 2022:
Critical evaluation and comparison of biomarker values in commercial CSF with Lumipulse® to support assay development for clinical trials.